person

L.F.D. (Lize) V. V.

Country
The Netherlands
Department
N/A

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 23 partner sites.

Specializations

Oncology – Solid Tumors

Focuses on advanced solid malignancies across multiple organ systems, emphasizing targeted and immunotherapeutic strategies.

  • Non‑Small Cell Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Renal Cell Carcinoma
  • Pancreatic Adenocarcinoma

Investigations include molecular profiling and combination regimens to improve response durability.

Hematology – Blood Cancers

Dedicated to the study of hematologic malignancies, integrating novel cellular therapies and targeted agents.

  • Acute Myeloid Leukemia
  • Diffuse Large B‑Cell Lymphoma
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia
  • Myelodysplastic Syndromes

Efforts aim to enhance remission rates and extend survival through precision medicine.

Cardiovascular & Metabolic Disease

Explores cardiovascular pathology and metabolic risk factors, with attention to atherosclerosis and heart failure.

  • Peripheral Arterial Disease
  • Atherosclerotic Cardiovascular Disease
  • Heart Failure with Reduced Ejection Fraction
  • Elevated Lipoprotein(a)
  • Hypertriglyceridemia

Research targets innovative lipid‑lowering and hemodynamic therapies.

Neurology & Neurodegeneration

Concentrates on neurodegenerative and cerebrovascular disorders, aiming to modify disease progression.

  • Amyotrophic Lateral Sclerosis
  • Ischemic Stroke
  • Epilepsy
  • Multiple Sclerosis
  • Parkinsonian Syndromes

Clinical efforts include neuroprotective agents and advanced imaging biomarkers.

Autoimmune & Inflammatory Disorders

Addresses immune‑mediated inflammatory diseases through targeted immunomodulation.

  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Atopic Dermatitis
  • Primary Sjögren's Syndrome

Studies evaluate biologic agents and pathway‑specific inhibitors to achieve disease control.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.